Pfizer and biontech receive u.s. fda emergency use authorization of covid-19 vaccine booster for individuals 12 years of age and older

New york & mainz, germany--(business wire)--pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the u.s. food and drug administration (fda) has expanded the emergency use authorization (eua) of a booster dose of the pfizer-biontech covid-19 vaccine to include individuals 12 years of age and older. the booster dose is the same dosage strength (30-Μg) as the dose approved in the primary series. a booster dose of the pfizer-biontech covid-19 vaccine was previously authorize
BNTX Ratings Summary
BNTX Quant Ranking